Edition:
United States

Galenica AG (GALE.S)

GALE.S on Swiss Exchange

49.05CHF
15 Dec 2017
Change (% chg)

CHF0.60 (+1.24%)
Prev Close
CHF48.45
Open
CHF48.20
Day's High
CHF49.05
Day's Low
CHF48.20
Volume
1,296,407
Avg. Vol
138,921
52-wk High
CHF49.15
52-wk Low
CHF41.80

Summary

Name Age Since Current Position

Joerg Kneubuehler

57 2017 Chairman of the Board of Directors

Jean-Claude Clemencon

55 2017 Chief Executive Officer and Head of Business Sector Retail

Felix Burkhard

51 2017 Chief Financial Officer

Christoph Amstutz

54 2017 Head of Business Sector Service

Torvald De Coverly veale

57 2017 Head of Business Sector Products and Brands

Daniela Bosshardt-Hengartner

45 2017 Member of the Board of Directors

Michel Burnier

64 2017 Member of the Board of Directors 

Fritz Hirsbrunner

68 2017 Member of the Board of Directors 

Philippe Nussbaumer

48 2017 Member of the Board of Directors 

Andreas Walde

55 2017 Member of the Board of Directors 

Biographies

Name Description

Joerg Kneubuehler

Dr. Joerg Kneubuehler is Chairman of the Board of Directors of Galenica Ltd. since 2017. He Joined the Galenica Group in 2002 as Head of Finance and Administration at Vifor Pharma; Head of Controlling for the Galenica Group as of 2006; Head Corporate Finance and Controlling for the Galenica Group and member of the Corporate Executive Committee since 2009; CFO since 2012 and Head Human Resources from 2012 until August 2014; from 2014 until end of 2016 CFO Galenica Group and CEO Galenica Santé.

Jean-Claude Clemencon

Mr. Jean-Claude Clemencon is Chief Executive Officer and Head of Business Sector Retail at Galenica Ltd. since 2017. He Galenica Ltd. He is member of the board of Helvacura cooperative society.

Felix Burkhard

Mr. Felix Burkhard is Chief Financial Officer at Galenica Ltd. since 2017. He served as Head of Strategic Projects since 2015 at the company. Previously he served as financial auditor at Revisuisse PriceWaterhouse.

Christoph Amstutz

Mr. Christoph Amstutz is Head of Business Sector Service at Galenica Ltd. since 2017. He serves as Head of business segment Services and member of the executive management Galenica Sante from September 2015. Previously he served as chief executive officer at G-Pharma AG, as general manager at UCB Pharma and as chief executive officer at Globopharm AG.

Torvald De Coverly veale

Mr. Torvald De Coverly veale is Head of Business Sector Products and Brands at Galenica Ltd. since 2017. He joined in 2015 as Head of Products and Brands at Galenica Sante. Previously he served at Birds Eye Walls and Unilever.

Daniela Bosshardt-Hengartner

Ms. Daniela Bosshardt-Hengartner is Member of the Board of Directors of Galenica Ltd. since 2017. She served as Financial analyst at Bank am Bellevue (1998-2002) and M2 Capital (2003-2004); Management consultant in the pharmaceutical, medical technology and biotechnology sectors since 2004; Member of the Board of Directors Galenica Group since 2008; Member of the Board of Directors of RepRisk AG (Zurich); Member of the Board of Directors of investiere.ch since 2017.

Michel Burnier

Prof. Dr. Michel Burnier is Member of the Board of Directors of Galenica Ltd. since 2017. He served as Member of the Medicines Committee of the Swiss Association of Pharmacists (until 2001), the Board of Swissmedic (2002-2010) and the Board of Directors of Speedel Holding Ltd. (2007-2009); Member of the following organisations: Swiss Society of Nephrology (former President), Scientific Council of the European Society of Hypertension (Treasurer) and Swiss Society of Hypertension (former President); Member of the Board of Directors Galenica Group since 2010.

Fritz Hirsbrunner

Mr. Fritz Hirsbrunner is Member of the Board of Directors of Galenica Ltd. since 2017. He joined the Galenica Group in 1977 as Assistant to the Corporate Executive Committee; CFO and member of the Corporate Executive Committee from 1992 to 2011; from 2009 Deputy CEO and CFO; Head Investor Relations until 2014; Member of the Board of Directors of Berlac AG, Sissach, and IVF Hartmann Holding AG, Neuhausen, Member of the Board of Trustees of IST Investmentstiftung, Zurich; Member of the Board of Directors of VenCap 6 Ltd., Jersey; Member of the Board of Directors Galenica Group since 2012.

Philippe Nussbaumer

Dr. Philippe Nussbaumer is Member of the Board of Directors of Galenica Ltd. since 2017. He serves as Director of the Pharmacie Centrale and the Pharmacie de la Gare in La Chaux-de-Fonds and of Veripharm SA; Since 2007, founder and director of the ECOPHARMA pharmacy brand; Since 2014, founder and director of the Medi-Centre SA medical centre (La Chaux-de-Fonds); Since 2004, Vice-President of Swiss Ski School Neuchâtel-Les Bugnenets.

Andreas Walde

Dr. Andreas Walde is Member of the Board of Directors of Galenica Ltd. since 2017. He held various legal and management positions in the chemical and pharmaceutical industry for 25 years 1988-1996 Roche, 1998-2010 Clariant and 2012-2013 Petroplus, in the two latter ones as group general counsel; Since 2013 General Secretary of the Galenica Group; Former positions include memberships on the boards of several private and (non-Swiss) public listed companies as well as on the board of the Society of Swiss Enterprises in Germany